Period-tracking apps pose ‘significant risks' for users, new report finds
Menstrual cycle tracking apps could jeopardize the safety and privacy of users, a new report warns, with personal data commonly sold to companies.
The stakes are high since period tracking apps have soared in popularity and become ubiquitous amid limited access to information, a lack of research and stigma about menstruation health.
A 2024 study estimates that global downloads for the three most popular menstruation cycle tracking apps surpassed 250 million.
Those who use apps that track periods often don't consider the data 'intimate' or commercially valuable, and need more protections from potential abuse of their personal information, according to the report released Tuesday by The Minderoo Centre for Technology and Democracy. MCTD is an independent team of academic researchers at the University of Cambridge in the U.K.
'Menstrual tracking applications turn personal health information into data points to be collected, analyzed, and sold,' according to the report.
Data sold to companies, advertisers
The study noted the apps pose 'significant risks' for users as femtech has become a 'lucrative trend' and the user data is 'extremely valuable' for a wide range of companies, from those that developed the app to big tech firms and advertising industries.
Femtech refers to digital products, services or technologies promoting women's health and wellbeing, with period-tracking apps making up 50 per cent of the US$22 billion market in 2020.
'People vastly underestimate the commercial value of menstrual data and the extent to which it can provide insights into their political preferences, health issues, or reproductive choices,' researchers wrote.
The apps offer a way for users to track daily information on anything related to their menstrual health, such as menstrual cycles, predictions on periods, premenstrual syndrome (PMS), ovulation and fertility.
Security and privacy risks
To add to the concerns, researchers say the apps also pose risks to data security and privacy, noting it's widely used in the online advertising industry.
'Self-tracking data has been used to police people's reproductive choices, to undermine a user's testimony in court, and it can lead to increased vulnerability in intimate relationships, partner violence, risks to job prospects via employer access to CTA (cycle tracking application) data, workplace monitoring, or possible health insurance discrimination,' according to the report.
Meanwhile, the report also referred to 'severe security risks,' noting an example in the U.K. where period tracker data was used to charge women for illegally accessing abortion services.
Are period apps accurate?
The study notes many medical studies showed that the apps 'fail to accurately calculate cycle length or ovulation windows' and additional data from people is often not used to improve predictions. Rather, researchers say the information is 'predominantly a source of value' for the companies.
'With most apps providing no or very little information on how predictions are made, a 2023 study found that some users were encouraged to track more data to fine-tune their predictions and train an imagined algorithm,' it wrote.
While users commonly turn to the apps to help them conceive or prevent getting pregnant, people with irregular cycles or conditions such as poly-cystic ovary syndrome, endometriosis, or premenstrual dysphoric disorder may also use the apps to try to understand their medical issues. Many people use the apps to track their emotions and bodily functions as well.
Recommendations
The report recommends improving health care for and incentivising research on menstrual and reproductive health, such as through cycle tracking companies and research institutes working together. It encourages schools and organizations to help raise awareness about menstrual tracking for all ages.
Additionally, it recommends alternatives, such as public bodies developing apps that are 'trustworthy' and collect data in a 'responsible way.'
The report also calls for stricter regulation of menstrual tracking data as 'sensitive health information' in the United States and tighter enforcement of existing regulations in the U.K. and European Union. It suggests improving security through 'consent options,' clear and accessible privacy policies, and prioritizing data privacy and security in the app design. Apps could be more 'transparent' by providing clear information on how tracking data is used to make predictions, with interface options for those who cannot or do not want to become pregnant.
The report notes that not all women menstruate and not everyone with menstrual cycles is a woman. For instance, it wrote that children and teenagers have periods, trans men can menstruate and trans women can experience symptoms similar to premenstrual syndrome (PMS). Most apps are designed for straight cis women who want to get pregnant, it added.
David Young, a privacy and regulatory law expert in Toronto, told CTVNews.ca in a video interview Monday that Canada's Personal Information Protection and Electronic Documents Act already follows the report's recommendations, though the law is 'not always enforced.'
According to Canada's federal privacy law, an organization must not require individuals to consent to the collection, use or disclosure of their information beyond 'explicitly specified, and legitimate purposes.'
'Assuming those specific and legitimate purposes are the tracking that the individual is seeking by use of the app, then they shouldn't be allowed to also require, as a condition of using the app, that they're going to sell that information to somebody else,' Young said. He noted Canada also faces a problem with companies selling consumers' medical data, including electronic health records.
Young said menstrual-related cycle data is considered 'sensitive personal health information.'
'And that has a very high standard of compliance under any privacy law, meaning that there must be clear ... consent to for whatever uses are going to be made of that information. So it's not something you can just use by way of implied consent.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
17 hours ago
- CTV News
A plague mysteriously spread from Europe into Asia 4,000 years ago. Scientists now think they may know how
The Great Plague of London in 1665, depicted here, was found to be caused by Yersinia pestis. Universalvia CNN Newsource For thousands of years, a disease repeatedly struck ancient Eurasia, quickly spreading far and wide. The bite of infected fleas that lived on rats passed on the plague in its most infamous form — the Black Death of the 14th century — to humans, and remains its most common form of transmission today. During the Bronze Age, however, the plague bacterium, Yersinia pestis, had not yet developed the genetic tool kit that would allow later strains to be spread by fleas. Scientists have been baffled as to how the illness could have persisted at that time. Now, an international team of researchers has recovered the first ancient Yersinia pestis genome from a nonhuman host — a Bronze Age domesticated sheep that lived around 4,000 years ago in what is now modern-day Russia. The discovery has allowed the scientists to better understand the transmission and ecology of the disease in the ancient past, leading them to believe that livestock played a role in its spread throughout Eurasia. The findings were published Monday in the journal Cell. 'Yersinia pestis is a zoonotic disease (transmitted between humans and animals) that emerged during prehistory, but so far the way that we have studied it using ancient DNA has been completely from human remains, which left us with a lot of questions and few answers about how humans were getting infected,' said lead author Ian Light-Maka, a doctoral researcher at the Max Planck Institute for Infection Biology in Berlin. There have been nearly 200 Y. pestis genomes recovered from ancient humans, the researchers wrote. Finding the ancient bacterium in an animal not only helps researchers understand how the bacterial lineage evolved, but it could also have implications for understanding modern diseases, Light-Maka added via email. 'Evolution can sometimes be 'lazy,' finding the same type of solution independently for a similar problem — the genetic tools that worked for pestis to thrive for over 2000 years across over Eurasia might be reused again.' Unraveling the mystery of a Bronze Age plague plague Excavations on the Eurasian Steppe have yielded thousands of animal bones from Bronze Age livestock. Courtesy Taylor Hermes via CNN Newsource The ancient bacterium that caused the Eurasia plague, known today as the Late Neolithic Bronze Age lineage, spread from Europe all the way to Mongolia, with evidence of the disease found across 6,000 kilometres (3,700 miles). Recent evidence suggests that the majority of modern human diseases emerged within the last 10,000 years and coincided with the domestication of animals such as livestock and pets, according to a release from the German research institute. Scientists suspected that animals other than rodents were a part of the enormous puzzle of the Bronze Age plague transmission, but without any bacterial genomes recovered from animal hosts, it was not clear which ones. To find the ancient plague genome, the study authors investigated Bronze Age animal remains from an archaeological site in Russia known as Arkaim. The settlement was once associated with a culture called Sintashta-Petrovka, known for its innovations in livestock. There, the researchers discovered the missing connection — the tooth of a 4,000-year-old sheep that was infected with the same plague bacteria found in humans from that area. Finding infected livestock suggests that the domesticated sheep served as a bridge between the humans and infected wild animals, said Dr. Taylor Hermes, a study coauthor and an assistant professor of anthropology at the University of Arkansas. 'We're sort of unveiling this in real time and trying to get a sense for how Bronze Age nomadic herders out in the Eurasian Steppe were setting the stage for disease transmission that potentially led to impacts elsewhere,' Hermes said, 'not only in later in time, but also in a much more distant, distant landscape.' During this time within the Eurasian Steppe, as many as 20% of the bodies in some cemeteries are those of people who were infected with, and most likely died from, the plague, making it an extremely pervasive disease, Hermes said. While livestock are seemingly a part of what made the disease so widespread, they are only one piece of the puzzle. The identification of the bacterial lineage in an animal opens new avenues for researching this disease's evolution as well as the later lineage that caused the Black Death in Europe and the plague that's still around today, he added. plague The Y. pestis genome was recovered from this 4,000 year old sheep tooth. Courtesy Taylor Hermes via CNN Newsource 'It's not surprising, but it is VERY cool to see (the DNA) isolated from an ancient animal. It's extremely difficult to find it in humans and even more so in animal remains, so this is really interesting and significant,' Hendrik Poinar, evolutionary geneticist and director of the Ancient DNA Centre at McMaster University in Hamilton, Ontario, wrote in an email. Poinar was not involved with the study. It is likely that humans and animals were passing the strains back and forth, but it isn't clear how they did so — or how sheep were infected in the first place. It is possible sheep picked up the bacteria through a food or water source and then transmitted the disease to humans via the animal's contaminated meat, he added. 'I think it shows how extremely successful (if you want to label it that way) this particular pathogen has been,' Poinar added. He, as well as the study's authors, said they hope that further research uncovers other animals infected with the ancient strain to further the understanding of the disease's spread and evolution. Ancient plague to modern plague While the plague lineage that persisted during the Bronze Age is extinct, Yersinia pestis is still around in parts of Africa and Asia as well as the western United States, Brazil and Peru. But it's rare to encounter the bacteria, with only 1,000 to 2,000 cases of plague annually worldwide. There is no need for alarm when it comes to dealing with livestock and pets, Hermes said. The findings are a reminder that animals carry diseases that are transmittable to humans. Be cautious when cooking meat, or to take care when bitten by an animal, he added. 'The takeaway is that humans aren't alone in disease, and this has been true for thousands of years. The ways we are drastically changing our environment and how wild and domesticated animals are connected to us have the potential to change how disease can come into our communities,' Light-Maka said. 'And if you see a dead prairie dog, maybe don't go and touch it.'
Globe and Mail
a day ago
- Globe and Mail
ClariMed Inc. Acquires We Are Human, Expanding Growth into Southeast Market
We Are Human's Expert Team and Atlanta-Based Usability Lab Join ClariMed's Growing Network; Founder Annmarie Nicolson Appointed as Principal CHADDS FORD, Pa. , Aug. 12, 2025 /CNW/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced the strategic acquisition of We Are Human, a UK and US-based consultancy specializing in user-focused design and research in MedTech innovation. The acquisition expands ClariMed's geographic reach into the Southeast through We Are Human's state-of-the-art Atlanta research facility while advancing the company's mission to enable innovative, human-centered medical technologies and make them accessible to communities that need them. Annmarie Nicolson , founder of We Are Human, will join ClariMed as Principal, bringing her extensive experience in early-stage formative research, contextual inquiry, and UX research for MedTech innovation to the leadership team. The acquisition brings the complete We Are Human team and their Atlanta research facility into the ClariMed family, expanding the company's presence in the Southeast region. "This acquisition represents our continued commitment to our user-centered foundation while expanding our reach and strengthening our capabilities," said Kelley Kendle , CEO of ClariMed. "Regional variability allows us to better address our patients' needs and advance our mission to make medical technology safer, more intuitive, and more impactful for the people who need it most. This isn't just a merger of capabilities — it's a deep alignment of values." The acquisition strengthens ClariMed's position as an integrated medical device services partner, expanding specialized expertise in user experience research, regulatory compliance, and design validation across both US and UK markets. We Are Human brings ISO 13485 certification and extensive experience with IEC-62366 and FDA Guidance requirements, having conducted research with hundreds of healthcare professionals, lay persons and diverse patient groups. The Atlanta laboratory will serve as ClariMed's newest research facility, offering access to diverse study populations in the Southeast while supporting the company's growing client base. "Joining ClariMed represents an exciting opportunity to amplify our impact in healthcare through human-centered research and design," said Annmarie. "Both organizations have a long-standing commitment to putting users first and creating products that truly make a difference in people's lives. This shared dedication to excellence and user-centered principles positions us to deliver even more meaningful solutions- both to our clients and, to the patients and healthcare providers who rely on innovative medical technology every day." The integration of We Are Human establishes ClariMed's first Southeast location, joining strategic offices across the United States and internationally, including Chadds Ford, PA ; Cambridge, MA ; San Jose, CA ; Cambridge, UK ; Leeds, UK ; and now Atlanta, GA. This expanded geographic network enhances ClariMed's ability to serve global clients while accessing diverse talent pools and participant populations for user research and usability testing. This acquisition aligns with ClariMed's growth strategy of building comprehensive, human-centered solutions for medical device development. The combined expertise of both organizations positions ClariMed to better serve pharmaceutical and medical device manufacturers seeking to accelerate time to market while enhancing patient safety and user experience. About ClariMed ClariMed is a human-centered development and regulatory practice for medical products developed by pharmaceutical and medical device manufacturers. Our best-of-breed professional services cultivate innovation while ensuring the safe and effective use of medical products. With offices across the United States and United Kingdom , ClariMed delivers comprehensive solutions that integrate human factors at the core of device development and regulatory pathways. Visit us at About We Are Human Founded in 2020, We Are Human is an ISO 13485 certified consultancy, based in the UK and US specializing in Human Factors, User Research and UX, with deep expertise in human-centered research and design for healthcare. The company was founded on the belief that human needs should be at the heart of design, striving to improve quality of life, health, and wellbeing through product development. We Are Human brings extensive experience in Human Factors and Usability Engineering standards and regulatory requirements for medical device development, including IEC-62366 and FDA Guidance, with a track record of collaborating with clients across Medical Devices, Combination Products, FemTech, Digital Health and over-the-counter (OTC) products.
CTV News
2 days ago
- CTV News
CTV News: Scientists gather in Quebec to study carbon storage beneath muddy seafloor
Scientists from U.K. and Université Laval gathered in Quebec City to study how and when the muddy seafloor stores carbon. Sarah Plowman reports.
